Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
IUBMB Life ; 74(1): 24-28, 2022 01.
Article in English | MEDLINE | ID: covidwho-1296787

ABSTRACT

Research on oxidants and electrophiles has shifted from focusing on damage to biomolecules to the more fine-grained physiological arena. Redox transitions as excursions from a steady-state redox set point are continually ongoing in maintenance of redox balance. Current excitement on these topics results from the fact that recent research provided mechanistic insight, which gives rise to more concrete and differentiated questions. This Commentary focuses on redox eustress and the feedback restoration of steady state as concepts in active maintenance of physiological health, with brief discussion of redox stress response to viral infection, exemplified by COVID-19.


Subject(s)
COVID-19/metabolism , Homeostasis , Oxidation-Reduction , SARS-CoV-2 , COVID-19/immunology , Feedback, Physiological , Hormesis , Host Microbial Interactions/immunology , Host Microbial Interactions/physiology , Humans , Immunity, Innate , Models, Biological , NF-E2-Related Factor 2/metabolism , Oxidative Stress , SARS-CoV-2/immunology , SARS-CoV-2/pathogenicity
2.
Ageing Res Rev ; 67: 101308, 2021 05.
Article in English | MEDLINE | ID: covidwho-1091952

ABSTRACT

Corona virus disease 2019 (COVID-19) is a global emergency able to overwhelm the healthcare capacities worldwide and to affect the older generation especially. When addressing the pathophysiological mechanisms and clinical manifestations of COVID-19, it becomes evident that the disease targets pathways and domains affected by the main aging- and frailty-related pathophysiological changes. A closer analysis of the existing data supports a possible role of biological age rather than chronological age in the prognosis of COVID-19. There is a need for systematic, consequent action of identifying frail (not only older, not only multimorbid, not only symptomatic) persons at risk of poor outcomes.


Subject(s)
COVID-19 , Frailty , Aging , Frailty/diagnosis , Humans , Multimorbidity , SARS-CoV-2
3.
J Biol Chem ; 295(39): 13458-13473, 2020 09 25.
Article in English | MEDLINE | ID: covidwho-1023994

ABSTRACT

My interest in biological chemistry proceeded from enzymology in vitro to the study of physiological chemistry in vivo Investigating biological redox reactions, I identified hydrogen peroxide (H2O2) as a normal constituent of aerobic life in eukaryotic cells. This finding led to developments that recognized the essential role of H2O2 in metabolic redox control. Further research included studies on GSH, toxicological aspects (the concept of "redox cycling"), biochemical pharmacology (ebselen), nutritional biochemistry and micronutrients (selenium, carotenoids, flavonoids), and the concept of "oxidative stress." Today, we recognize that oxidative stress is two-sided. It has its positive side in physiology and health in redox signaling, "oxidative eustress," whereas at higher intensity, there is damage to biomolecules with potentially deleterious outcome in pathophysiology and disease, "oxidative distress." Reflecting on these developments, it is gratifying to witness the enormous progress in redox biology brought about by the science community in recent years.


Subject(s)
Hydrogen Peroxide/metabolism , Glutathione/metabolism , Humans , Oxidation-Reduction , Oxidative Stress
4.
Free Radic Biol Med ; 156: 107-112, 2020 08 20.
Article in English | MEDLINE | ID: covidwho-620858

ABSTRACT

Ebselen is an organoselenium compound exhibiting hydroperoxide- and peroxynitrite-reducing activity, acting as a glutathione peroxidase and peroxiredoxin enzyme mimetic. Ebselen reacts with a multitude of protein thiols, forming a selenosulfide bond, which results in pleiotropic effects of antiviral, antibacterial and anti-inflammatory nature. The main protease (Mpro) of the corona virus SARS-CoV-2 is a potential drug target, and a screen with over 10,000 compounds identified ebselen as a particularly promising inhibitor of Mpro (Jin, Z. et al. (2020) Nature 582, 289-293). We discuss here the reaction of ebselen with cysteine proteases, the role of ebselen in infections with viruses and with other microorganisms. We also discuss effects of ebselen in lung inflammation. In further research on the inhibition of Mpro in SARS-CoV-2, ebselen can serve as a promising lead compound, if the inhibitory effect is confirmed in intact cells in vivo. Independently of this action, potential beneficial effects of ebselen in COVID-19 are ascribed to a number of targets critical to pathogenesis, such as attenuation of inflammatory oxidants and cytokines.


Subject(s)
Antioxidants/therapeutic use , Antiviral Agents/therapeutic use , Azoles/therapeutic use , Betacoronavirus/drug effects , Coronavirus Infections/drug therapy , Organoselenium Compounds/therapeutic use , Pandemics , Pneumonia, Viral/drug therapy , Viral Nonstructural Proteins/antagonists & inhibitors , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Betacoronavirus/enzymology , Betacoronavirus/pathogenicity , Binding Sites , COVID-19 , Coronavirus 3C Proteases , Coronavirus Infections/epidemiology , Coronavirus Infections/metabolism , Coronavirus Infections/virology , Cysteine Endopeptidases/chemistry , Cysteine Endopeptidases/metabolism , Host-Pathogen Interactions/drug effects , Host-Pathogen Interactions/genetics , Humans , Isoindoles , Lung/drug effects , Lung/metabolism , Lung/pathology , Lung/virology , Models, Molecular , Oxidative Stress/drug effects , Pneumonia, Viral/epidemiology , Pneumonia, Viral/metabolism , Pneumonia, Viral/virology , Protease Inhibitors/therapeutic use , Protein Binding , Protein Structure, Secondary , Reactive Oxygen Species/antagonists & inhibitors , Reactive Oxygen Species/metabolism , SARS-CoV-2 , Viral Nonstructural Proteins/chemistry , Viral Nonstructural Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL